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Background: Peripherally inserted central catheters (PICCs) removed prematurely for unconﬁrmed in-
fection or thrombosis lead to subsequent reinsertions and associated complications. To improve clinical
quality, a mandatory electronic communication tool (MECT) based on clinical practice guidelines was man-
dated for all inpatient adult PICCs in an academically aﬃliated tertiary medical center. This MECT facilitated
early communication and specialized evaluation with the PICC team for any complications related to PICCs.
Methods: A historical cohort study was conducted. Quality and cost measurements for 200 PICCs
postinstitution of a MECT were compared with 200 PICCs 12 months prior. PICC removal and complica-
tion rates were compared for the 2 cohorts.
Results: Signiﬁcant outcomes included a central-line associated blood stream infection rate that changed
from 1.38/1,000 catheter days to 0/1,000 catheter days, 0 provider-led premature PICC removals, an overall
84% decrease in premature PICC removals (from 16%-2.5%; P < .0001), a decrease in the total complica-
tion rate from 45.5%-24% (P < .0001), and 25% reduction in radiology costs.
Conclusion: A novel infection prevention approach leveraging a MECT resulted in 0 central line-
associated bloodstream infections and provider-led premature PICC removals.
© 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier
Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Multiple clinical practice guidelines offer evidence-based rec-
ommendations for the prevention andmanagement of intravascular
catheter-related infections. Particular attention has been focused
on catheter insertion andmanagement practices based on the results
of the 2006 Michigan Keystone project.1 More than 1,500 lives and
nearly $200 million in savings were attributed over an 18-month
period to utilizing an insertion checklist and patient safety inter-
vention bundle.1
In comparison, much less attention has been given to central
venous catheter (CVC) removal practices. Clinical practice guide-
lines and multidisciplinary policies unanimously advocate for
removing unnecessary CVCs as a way to prevent intravascular
catheter-related infections.2 Unfortunately, a hazard of this move-
ment is the unintended premature removal of peripherally inserted
central catheters (PICCs) intended for intermediate- to long-term
use.
Approximately 40% of adult inpatient PICCs are removed before
completion of their intended therapy.3-9 Premature PICC removals
* Address correspondence to Sue J. Kim-Saechao, RN, DNP, FNP, Division of Vascular
and Interventional Radiology, Department of Radiological Sciences, University of
California Los Angeles Medical Center, Los Angeles, CA 90095.
E-mail address: suesaechao@yahoo.com, ssaechao@mednet.ucla.edu (S.J.
Kim-Saechao).
This manuscript is original, unpublished, and not in consideration elsewhere.
All authors participated in manuscript preparation, in writing the manuscript, and
had access to the data. No conﬂict of interest exists for authors and there were no
funding sources.
Author Information: Sue Kim-Saechao is an interventional radiology nurse prac-
titioner at UCLA. She received her BSN at the University of Maryland, MSN at UCLA,
and DNP at Johns Hopkins University. She is actively engaged in the insertion, man-
agement, and removal of PICCs.
Author Information: Earl Almario is a PICC nurse at UCLA. He received his BSN
at the Central Philippine University. He is actively engaged in the insertion, man-
agement, and removal of PICCs.
Author Information: Zach Rubin is the director of clinical epidemiology and in-
fection prevention at UCLA. He received his MD from the University Of Arizona College
Of Medicine. He is actively engaged PICC infection surveillance and instituting in-
fection prevention initiatives.
Conﬂicts of Interest: None to report.
0196-6553/© 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
http://dx.doi.org/10.1016/j.ajic.2016.03.023
American Journal of Infection Control 44 (2016) 1335-45
Contents lists available at ScienceDirect
American Journal of Infection Control
journal homepage: www.aj ic journal .org
American Journal of 
Infection Control
are PICCs removed before completion of intended therapy that do
not meet the US National Healthcare Safety Network (NHSN) of the
Centers for Disease Control and Prevention (CDC) central-line as-
sociated blood stream infection (CLABSI) criteria, or catheters
removed for suspected deep vein thrombosis (DVT) without imaging
conﬁrmation. Of note, there is a signiﬁcant body of literature sup-
porting continued use of PICCs for necessary therapy, even with
conﬁrmed thrombosis.
Common reasons for premature removal include mechanical
phlebitis, local cellulitis, catheter malposition, occlusion, mechan-
ical failure, unrelated fever, inadvertent patient removal, and
error.3,5,7-12 Many of these complications can easily be managed by
a specialty team with expertise in the insertion, management, and
removal of these catheters without premature removal.
Premature PICC removals for unconﬁrmed infection or throm-
bosis are signiﬁcant due to the need for subsequent reinsertions.
PICC reinsertions occur in up to 100% of patients, often within days,
to allow for CVC access and completion of therapy.13 Because pre-
vious catheters and placement attempts increase complications,
adherence to clinical practice guidelines is critical to prevent pre-
mature removals and subsequent reinsertions for completion of
therapy.14
PICC-associated complications can be a high as 20%-33% in non-
pregnant patients and up to 66% in pregnant patients with
hyperemesis.5,6,8,9,15-17 Typically, 0.6%-6.2% of PICC complications are
related to concerns over infection, 9.6%-10.8% due to mechanical
concerns, 8.2%-9.7% due to phlebitis, 2.6% due to pain, and 0.5%-
0.3% due to suspected venous thrombosis.9,17-19 PICC malpositions
also occur in 20%-30% of insertions, with more complications as-
sociated with patients who have had multiple catheters.10,20 Other
risks include bleeding, catheter migration, and radiologically guided
insertions requiring anesthesia.8,10,21,22 Furthermore, preservation of
vessels for future vascular access is particularly critical for an aging
population living longer with chronic conditions such as hyperten-
sion, diabetes, chronic kidney disease (CKD), cancer, bowel
obstruction, and organ transplant.22
The search strategy for premature PICC removal practice initia-
tives involved reviewing the literature regarding the general care
and maintenance of PICCs for continuation of therapy, the appro-
priate management of PICC complications, and those related to
decreasing PICC complications. Although there is a plethora of lit-
erature related to the general care and maintenance of these
catheters, there is minimal literature relating speciﬁcally to initia-
tives for premature PICC removals. PICC removal information, when
available, generally pertained to potential complications related to
the inability to remove PICCs and prevention of air emboli, rather
than to strategies speciﬁc to premature removal prevention.
The review of the literature provides the highest level of evidence-
based initiatives for the use of a specialized team for themaintenance
of intravascular catheters and education needs; an interdisciplin-
ary, collaborative approach to decrease complications and prevent
premature removal of PICCs; the implementation of institutional
policies, procedures, and protocols with strong organizational lead-
ership support for the prevention and management of PICC
complications; and the use of CVC surveillance and auditing to
detect, manage, and prevent complications such as premature PICC
removals.
Multiple clinical practice guidelines, including those from the
CDC and Society for Healthcare Epidemiology of America, recom-
mend specialization as a contributor to patient safety, outcomes,
and satisfaction.23-27 Within this team-based system, expert clini-
cians with competency in PICC use, site care, and catheter
maintenance with training to manage potential complications are
involved in PICC removal.22,28,29 Success is measured through high
insertion success rates; decreased infection, DVT, and complica-
tion rates; improved team patient safety practices; increased patient
and staff satisfaction with vascular access devices; and cost savings.30
Unfortunately, although specialized nursing-based CVC pro-
grams speciﬁc to vascular access are increasing due to the CDC
category IA recommendation to establish a designated nursing team,
a US survey of 53 hospitals published in 2000 revealed that only
19% had a designated vascular team.31,32 In other institutions, al-
though specialized teams exist, complications may not be managed
appropriately because multiple medical and nursing teams with
limited communicationmanage these catheters across their lifespans.
PICCs have been preserved by encouraging early interdisciplin-
ary communication to facilitate the management of complications.13
In 1 study,13 of the 32% of PICCs removed before completion of
therapy, 21.6% could have beenmanagedwithout premature removal.
Interdisciplinary communication facilitated the exclusion of
noncatheter-associated sources of fever and promoted the appro-
priate management of catheter occlusion, rupture, or partial
unintentional removal without removal.13,24,25,33
In September 2012, our institutional review board approved a
multidimensional quality improvement study leveraging a man-
datory electronic communication tool (MECT) with the primary goal
of decreasing premature PICC removal rates and a secondary goal
of decreasing PICC-associated complications and costs. The study
sought to facilitate the exchange of evidence-based recommenda-
tions between interdisciplinary team members utilizing early
communication and specialty evaluation.
MATERIALS AND METHODS
Study design, end points, and setting
This historical cohort quality improvement study compared 2 dif-
ferent cohorts separated by time for comparison (12 months
separating both cohorts) at an academically aﬃliated tertiarymedical
center in Southern California. A 12-month period between the 2
cohorts was chosen to account for changes in new medical house
staff at American teaching institutions every June and July. The study
units included all adult inpatient areas, including adult medicine,
surgery, hematology/oncology, pulmonary/intensive care, geriat-
rics, orthopedics, emergency department, and the procedure
treatment unit.
Following institutional review board approval, baseline data col-
lection of 200 consecutive adult inpatient PICCs (cohort 1) inserted
starting September 24, 2011 (12 months preceding data collec-
tion for cohort 2) was performed utilizing retrospective chart review.
These data were compared with data collected from 200 consec-
utive adult inpatient PICCs (cohort 2) postinstitution of an MECT
starting September 24, 2012. Although all adult inpatients re-
ceived the intervention after September 24, 2012, data were only
collected from the ﬁrst 200 adult inpatient PICCs in cohort 2 for this
study. Postintervention data collection was extended to at least 1
month after the sample of 200 was met for each cohort to evalu-
ate for completion of therapy.
The primary study end point was a 50% decrease in the prema-
ture PICC rate from baseline and a 25% decrease in complications
and costs related to decreased premature PICC removal. The inclu-
sion criteria for both cohorts was the ﬁrst 200 adult inpatient PICCs
placed during each speciﬁed data collection period. Exclusion cri-
teria were pediatric PICCs, adult outpatient PICCs, and adult inpatient
PICCs outside the data collection period for both cohorts.
Structural components contributing to premature PICC remov-
als within this health system included the lack of a multidisciplinary
team to evaluate vascular access/removals, the lack of a formal re-
ferral process for PICC removals, issues with continuity of care,
frequent changes in medical house staff within large teaching
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institutions, and the lack of an electronic database to track inser-
tion and removal of PICCs. Process components contributing to
premature PICC removals included an outdated institutional pro-
tocol related to management of PICCs by a specialty team, an
outdated PICC removal tool, knowledge gaps with regard to clini-
cal practice guidelines, and minimal awareness of the removal
problem by administration and staff.
Multidisciplinary leadership support from the medical director
of clinical epidemiology and infection prevention, the chief medical
oﬃcer, the director of nursing, medical information and technol-
ogy services, as well as multidisciplinary nursing andmedical teams
was cemented before implementation. Stakeholders included the
PICC service, interventional radiology (IR), infection control,
pulmonology/critical care, medicine and nursing leadership, and ad-
ministrators for all adult inpatient areas. An e-mail letter of
leadership support was sent from the chief medical oﬃcer and di-
rector of nursing to all medical and nursing staff regarding theMECT
protocol change. Multidisciplinary auditing was also initiated to eval-
uate for compliance to the MECT. For successful implementation of
evidence-based recommendations and to promote change, strong
organizational and administrative support and facilitation was
required.27,30
On September 24, 2012, an MECT was instituted for all adult in-
patient PICCs during business hours, Monday through Friday 8:00
a.m. through 5:00 p.m., excluding holidays and university clo-
sures (Fig 1). As indicated prominently at the top of theMECT, MECTs
outside of those restrictions would be evaluated the next business
day and would not change standard of care. The MECT would not
change a provider’s ability to immediately discontinue PICCs for pa-
tients meeting CDC criteria for sepsis or deemed high risk.
Additionally, the MCET recommended paging the PICC team for any
urgent requests.
MCETs could be accessed by the PICC team at any computer using
a protected health system 2007 Outlook (Microsoft Corp, Redmond,
WA) shared network PICC account, without requiring the provider
to ﬁnd a paper copy. Historically, paper orders had been faxed to
the wrong department, or not at all, causing delay of care. Order-
ing providers were paged to use the MECT if orders were received
in alternate fashion. If necessary, the PICC team will then contact
multidisciplinary team members, such as a patient’s staff nurse,
medical team, and specialty teams to coordinate appropriate care,
including removal.
The MECT allowed for early communication and specialty man-
agement so PICCs not meeting CDC and DVT removal criteria could
be salvaged, especially for those patients with limited vascular access.
Specialized PICC management may include individualized patient
assessment; repositioning malpositioned PICCs; performing over-
the-guidewire PICC exchange; declotting occluded PICCs;
recommending speciﬁc diagnostic or laboratory testing, according
to CDC and DVT criteria; preventing accidental PICC reinsertion into
thrombosed vessels; and optimal reinsertion management for those
with suspected bacteremia or fungemia. The MECT also allows both
the PICC team and infection control to monitor PICCs for compli-
cation tracking because the MECT is transmitted electronically to
both teams.
Multidimensional implementation elements also included daily
paging on weekdays to all nurses with patients with PICCs regard-
ing theMECT; a PowerPoint (Microsoft Corp) presentation providing
medical and nursing staff with updated instructions and indica-
tions for use of the MECT; multidisciplinary (nursing and medicine)
communication about the MECT via group e-mail, individually with
PICC insertions, and in PowerPoint presentations at committeemeet-
ings, not limited to the multidisciplinary infection control
committees, the clinical nurse specialist and unit director commit-
tee; PICC team, and subspecialty committees; and patient and
family education about the MECT with any PICC insertion or
encounter.
Deﬁnitions
Premature PICC removals are deﬁned as PICCs removed before
completion of intended therapy and do not meet the CDC CLABSI
criteria or catheters removed for suspected DVT without imaging
conﬁrmation.
The NHSN deﬁnition of CLABSI was used to review all positive
PICC blood cultures by clinical epidemiology and infection preven-
tion departments. To meet the deﬁnition of a CLABSI, the patient
with the PICC must have had the PICC in place with a recognized
pathogen cultured from 1 or more blood cultures and the organ-
ismmust not be related to an infection at another site (ie, a secondary
bloodstream infection); or a common skin organism was cultured
from 2 or more blood cultures drawn on separate occasions (within
2 days of each other) and at least 1 of the following signs or symp-
toms are present: fever (38°C), chills, or hypotension, and the signs
and symptoms and positive blood cultures are not due to infec-
tion at another site. The denominator for bloodstream infection rates
was 1,000 CVC days.
Statistical methods
The sample size estimate was derived from an estimated rate
of premature PICC removals of 20% within this Southern Califor-
nia university health system in 2011. On the basis of published
studies, it was assumed that early communication and specialty eval-
uation would result in a 50% decrease in premature PICC removal
rates. To achieve a statistically signiﬁcant decrease (P = .05) in pre-
mature PICC removals with a power of 80%, the sample size estimate
was 200 PICCs each for the baseline (cohort 1) and intervention group
(cohort 2). Analyses were conducted using SPSS version 20 (IBM Corp,
Armonk, NY). To analyze the difference in cohorts, χ2 for homoge-
neity tests were used, including premature PICC removal and
complication rates.
RESULTS
Data collection included demographic characteristics of the study
population (Table 1), catheter characteristics (Table 2), procedure
outcomes (Table 3), PICC removal rates (Table 4), PICC complica-
tion rates (Table 5), and types of PICC imaging used for PICC insertion
(Table 5). A total of 400 adult inpatient PICCs represents 100% of
the total sample size used for analysis (200 PICCs each for the base-
line and intervention group).
The primary desired outcome was a 50% decrease in prema-
ture PICC removal rates for adult inpatients before completion of
therapy, utilizing aMECT for early communication and specialty eval-
uation. The premature PICC removal rate for the baseline group
(cohort 1) was 16% and for the intervention group (cohort 2) 2.5%.
There was an 84.4% decrease in premature PICC removal rates
postintervention, which was statistically signiﬁcant (P < .0001) and
exceeded expected outcomes. All premature PICC removals in cohort
2 were due to patient self-removal (accidental or due to altered
mental status) and none were provider-led. The patient self-
removal rates for both cohorts were similar (2% for cohort 1 vs 2.5%
for cohort 2). Furthermore, although 10 patients in cohort 2 had con-
ﬁrmed DVT, only 1 had the PICC removed due to DVT. The others
had continued use of their PICC for completion of therapy. The total
PICC removal rates also decreased (P < .0001) due to reinforce-
ment of intermediate- to long-term PICC indications before PICC
insertion and removal.
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Secondary desired outcomes included a 25% decrease in PICC
complications and radiology costs due to decreased premature PICC
removal rates. There was a statistically signiﬁcant decrease in the
total PICC complication rate from 45.5% for cohort 1 to 34% (P < .001)
for cohort 2, particularly in PICC malposition (P < .001) and sus-
pected infection rates (P = .03). This represents a 25.3% decrease in
PICC complications, meeting secondary outcomes. Although sta-
tistical signiﬁcance was not achieved (P = .06), the greatest clinical
signiﬁcance was noted with CLABSI rates, which dropped from a
CLABSI rate of 1.38/1,000 catheter days (2.5%) from cohort 1 to
0/1,000 catheter days for cohort 2. The CLABSI rate of 1.39/1,000 cath-
eter days was calculated for cohort 1 by dividing the 5 CLABSIs by
3,614 catheter days (total catheter days for cohort 1) and multi-
plying it by 1,000. The CLABSI rate for cohort 2 was 0/1,000 catheter
days because there were no CLABSIs. The secondary bloodstream
infection rate for cohort 1 was 2.77/1,000 catheter days (10 sec-
ondary bloodstream infections were divided by 3,614 catheter days
and multiplied by 1,000) and 1.91/1,000 catheter days for cohort 2
Fig 1. Mandatory electronic communication tool.
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(5 secondary bloodstream infections were divided by 2,623 cath-
eter days and multiplied by 1,000).
In cohort 1, imaging required for PICC conﬁrmation, other than
chest radiograph (84%), included ﬂuoroscopy (3%), chest radio-
graph plus ﬂuoroscopy (1.5%), chest radiograph plus ﬂuoroscopy plus
venogram (1%), or multiple interventions (4%), such as Doppler ul-
trasound to evaluate for thrombosis (Table 6). The total imaging costs
for cohort 1 was $17,924.74 utilizing the Medicare B hospital fee
reimbursement schedule. The cost of 168 chest radiographs, in-
cluding the professional fee, was $5,493.60 and up to $12,000 for
the 12 referrals to IR for additional ﬂuoroscopic imaging. Eight ad-
ditional PICCs needed multiple studies and 1 required an upper
extremity Doppler study. The cost was estimated to be an addi-
tional $261.60 for the eight multiple studies requiring 2 chest
radiograph scans for successful PICC placement and another $169.54
for the Doppler study. To calculate cost for cohort 1, the 2011 Medi-
care B hospital fee reimbursement schedule was used, which allows
for $275.29 per ultrasound-guided PICC placement (CPT 36568 PICC
placement, CPT 76937 ultrasound); $32.70 for a portable 1-view
chest radiograph, including the professional fee (CPT 71010 and
revenue code 0972); $169.54 for a unilateral upper extremity venous
Doppler study (CPT 93971); $128.66 for venogram of a unilateral
extremity (CPT 75820); and $119.47 for ﬂuoroscopic conﬁrmation
(CPT 77001). Other costs when using IR include those related to the
radiologist’s professional fee, increased technologist and clinical staff
use, and disposables amounting to more than $1,000 per catheter
when ﬂuoroscopic assistance is required.
In cohort 2, imaging required for PICC conﬁrmation, other than
chest radiograph (89%), included ﬂuoroscopy (5%), and chest
radiograph plus ﬂuoroscopy (1%) (Table 6). The total imaging costs
for cohort 2 was $17,863.32 utilizing the Medicare B hospital fee
reimbursement schedule. The cost of 178 chest radiograph with the
professional fee was $5,863.32 and up to $12,000 for the 12 refer-
rals to IR for additional ﬂuoroscopic imaging. For cohort 2, the
Medicare B hospital fee reimbursement schedule allows for $266.98
per ultrasound-guided PICC placement (CPT 36568 PICC place-
ment, CPT 76937 ultrasound); $32.94 for a portable 1-view chest
radiograph, including the professional fee (CPT 71010 and revenue
code 0972); and $119.47 for ﬂuoroscopic conﬁrmation (CPT 77001).
Other costs include those related to the radiologist’s professional
fee, increased technologist and clinical staff use, and disposables
amounting to more than $1,000 per line when ﬂuoroscopic assis-
tance is required.
Despite very little difference in imaging costs for the 2 cohorts
($17,924.64 in imaging for cohort 1 and $17,863.32 for cohort 2),
there was a 35.4% savings in radiology costs in cohort 2 due to cost
Table 1
Demographic characteristics of the study population
Baseline
group
Intervention
group P value
Total number of peripherally
inserted central catheter
placements
200 200
Age (y) 68 (18-100) 63.19 (18-99)
Gender .55
Female 110 (55) 104 (52)
Male 90 (45) 96 (48)
Unit
Medical/surgical 89 (44.5) 82 (41)
Hematology/oncology 34 (17) 54 (27)
Pulmonary/intensive care unit 44 (22) 28 (14)
Geriatrics 21 (10.5) 5 (2.5)
Orthopedics 1 (0.5) 25 (12.5)
Other 11 (5.5) 12 (6)
Peripherally inserted central
catheter indication
.03
Antibiotics 130 (65) 123 (61.5)
Intravenous access 27 (13.5) 13 (6.5)
Chemotherapy 23 (11.5) 39 (19.5)
Total parenteral nutrition 17 (8.5) 24 (12)
Pressor 2 (1) 0 (0)
Other 1 (0.5) 1 (0.5)
Comorbidities
Coinfection 183 (91.5) 167 (83.5) .02
Miscellaneous 146 (73) 84 (42) < .0001
Cancer 86 (43) 101 (50.5) .13
Chronic kidney disease 40 (20) 19 (9.5) < .01
Autoimmune disorders 27 (13.5) 24(12) .65
Total parenteral nutrition 22 (11) 30 (15) .23
Coagulopathy 23 (11.5) 17 (8.5) .32
Lymph node dissection 14 (7) 6 (3) .07
Pacemaker/automatic
implantable cardioverter
deﬁbrillator
12 (6) 15 (7.5) .55
Vegetative valves 4 (2) 6 (3) .52
Axillary bypass surgery 2 (1) 1 (0.5)
Transplant 2 (1) 0 (0)
Thrombosis
History of deep vein thrombosis 37 (18.5) 45 (22.5) .32
History of multiple deep vein
thrombosis
22 (11) 24 (12) .75
History of central venous access
device
47 (23.5) 35 (17.5) .53
Short-term central venous access
device
23 (12.5) 11 (5.5)
More than 1 central venous
access device
12 (6) 11 (5.5)
Implanted port 6 (3) 8 (4)
Right dialysis catheter 3 (1.5) 4 (2)
Dialysis graft/ﬁstulas 2 (1) 0 (0)
Right tunneled central venous
catheter
1 (0.5) 1 (0.5)
Current central venous catheter 36 (18) 22 (11) .12
Short-term central venous
catheter
17 (3) 9 (4.5)
More than 1 central venous
catheter
11 (5.5) 2 (1)
Right dialysis catheter 2 (1) 5 (2.5)
Right implanted port 2 (1) 3 (1.5)
Right tunneled central venous
catheter
1 (0.5) 0 (0)
Other 1 (0.5) 1 (0.5)
NOTE. Values are presented as n, mean (range), or n (%). Bold values are statistical-
ly signiﬁcant P < .05.
Table 2
Peripherally inserted central catheter characteristics
Baseline
group
Intervention
group P value
Total number of catheters 200 200
Size .26
5 French 128 (64) 117 (58.5)
4 French 72 (36) 83 (41.5)
Manufacturer < .0001
Navilyst* 199 (99.5) 0 (0)
Arrow† 1 (0.5) 0 (0)
Bard‡ 0 (0) 200 (100)
Other 0 (0) 0 (0) .26
Number of lumens
Single 72 (36) 83 (41.5)
Double 128 (64) 117 (58.5)
Valve type
Nonvalved 100 (100) 100 (100)
Valved 0 (0) 0 (0) .63
Power injectable
Yes 190 (95) 192 (96)
No 10 (5) 8 (4)
NOTE. Values are presented as n or n (%). Bold values are statistically signiﬁcant
P < .05.
*Marlborough, MA.
†Morrisville, NC.
‡Salt Lake City, UT.
1339S.J. Kim-Saechao et al. / American Journal of Infection Control 44 (2016) 1335-45
savings from decreased premature removals. The catheter and ra-
diography costs for the 27 PICCs removed prematurely in cohort 1
utilizing the 2011 Medicare B hospital fee reimbursement sched-
ule was at least $9,717, making the additional radiology and imaging
cost $27,641.74 for cohort 1 versus $17,863.32 for cohort 2. This ex-
ceeded the secondary desired outcome of a 25% decrease in radiology
costs due to reduced premature PICC removals.
For the purposes of this study, speciﬁc costs related to de-
creased rates of infection and complications, as well as length of
stay, were not calculated. Given an attributable cost estimate of up
to $45,000 per CVC-associated bloodstream infection and the higher
incidence of CLABSIs in the baseline group (5 PICCs), there are greater
implications for cost savings than those calculated for this study.1
Table 3
Procedure outcomes
Baseline
group
Intervention
group P value
Total peripherally inserted central
catheters
200 200
Catheter indicated
Peripherally inserted central
catheter
197 (98.5) 194 (97)
Midline catheter 3 (1.5) 6 (3)
Catheter placed
Peripherally inserted central
catheter
190 (95) 193 (96.5)
Midline catheter 9 (4.5) 7 (3.5)
Failed 1 (0.5) 0 (0)
Arm .91
Right 147 (73.5) 146 (73)
Left 53 (26.5) 54 (27)
Vein .001
Basilic 114 (57) 149 (73)
Brachial 71 (35.5) 41 (20.5)
Cephalic 15 (7.5) 10 (5.0)
Reinserted peripherally inserted
central catheter
1.0
Yes 33 (16.5) 33 (16.5)
No 167 (83.5) 167 (83.5)
Malposition <.001
Yes 34 (17) 10 (5.0)
No 167 (83.5) 190 (95)
Reposition .001
Yes 26 (13) 8 (4)
No 174 (87) 192 (96)
Peripherally inserted central
catheter provider
Peripherally inserted central
catheter registered nurse
138 (69) 132 (66)
Interventional radiology nurse
practitioner
60 (30) 67 (33.5)
Interventional radiology
physician
2 (1.0) 1 (0.5)
Interventional radiology referral 1.0
Yes 12 (6) 12 (6)
No 188 (94) 188 (94)
Interventional radiology provider
Registered nurse 4 (2) 1 (0.5)
Nurse practitioner 6 (3) 11 (5.5)
Physician 2 (1.0) 1 (0.5)
Success
Yes 199 (99.5) 200 (100)
No 1 (0.5) 0 (0)
Tip location
Distal superior vena cava 129 (64.5) 131 (65.5)
Mid-superior vena cava 44 (22) 40 (20)
Axillary vein 10 (5) 7 (3.5)
Proximal superior vena cava 9 (4.5) 16 (8)
Right atrium 3 (1.5) 4 (2)
Subclavian vein 2 (1) 1 (0.5)
Other 3 (1.5) 1 (0.5)
NOTE. Values are presented as n or n (%). Bold values are statistically signiﬁcant
P < .05.
Table 4
Peripherally inserted central catheter (PICC) removal
Baseline
group
Intervention
group P value
Total PICCs 200 200
Total removals 89 (44.5) 48 (24) < .0001
Total premature removals 32 (16) 5 (2.5) < .0001
Reason for removals
Completion of therapy 39 (19.5) 34 (17)
Early discontinuation 11 (5.5) 0 (0) .003
Infection:
Suspected 4 (2) 0 (0)
Secondary 5 (2.5) 5 (2.5) 1.0
Conﬁrmed central line-
associated bloodstream
infection
5 (2.5) 0 (0) .06*
Deep vein thrombosis
Conﬁrmed 4 (2) 1 (0.5)
Patient self-removal 4 (2) 5 (2.5)
Exchange by PICC team 4 (2) 3 (1.5)
PICC insertion delay
Yes 0 (0.0) 0 (0.0)
No 200 (100.0) 200 (100.0)
Average catheter days 18.2 13.2
NOTE. Values are presented as n or n (%). Bold values are statistically signiﬁcant
P < .05.
*Fisher exact test used; failed to meet the assumptions χ2 analysis.
Table 5
Peripherally inserted central catheter (PICC) complications
Baseline
group
Intervention
group P value
Total PICCs 200 200
Total number of complications 91 (45.5) 68 (34) .02
Multiple complications 23 (11.5) 16 (8) .62
Types of complications
Infection
Suspected 64 (32) 45 (22.5) .03
Conﬁrmed 10 (5) 5 (2.5) .06
Deep vein thrombosis
Suspected 18 (9) 19 (9.5) .86
Conﬁrmed 11 (5.5) 10 (5) .82
Malposition + suspected
infection
7 (3.5) 2 (1)
Suspected infection + deep vein
thrombosis
4 (2) 4 (2)
Malposition + central line-
associated bloodstream
infection
1 (0.5) 0 (0)
Malposition + deep vein
thrombosis
1 (0.5) 1 (0.5)
Infection + deep vein thrombosis 1 (0.5) 0 (0)
Infection + suspected deep vein
thrombosis
1 (0.5) 1 (0.5)
Other 4 (2) 6 (3)
Multiple 3 (1.5) 2 (1)
NOTE. Values are presented as n or n (%). Bold values are statistically signiﬁcant
P < .05.
Table 6
Peripherally inserted central catheter (PICC) imaging
Baseline
group
Intervention
group P value
Total PICCs 200 200
Chest radiograph only 168 (84) 168 (84)
Interventional radiology referral 12 (6) 12 (6) 1.0
Fluoroscopy 6 (3) 6 (3)
Chest radiograph + ﬂuoroscopy o 3 (1.5) 3 (1.5)
Chest radiograph + ﬂuoroscopy +
venogram
2 (1) 2 (1)
Multiple interventions 8 (4) 8 (4)
Other 2 (1) 2 (1)
NOTE. Values are presented as n or n (%).
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Cohort 1 had a CLABSI rate of 2.5% (5 PICCs) versus 0% for cohort
2. The attributable cost would amount up to $225,000 for the in-
tervention period, if this model were used. Adding in $9,717 in cost
savings from decreased PICC removals, the total amount saved during
the 5-month intervention period (amount of time required to collect
data for 200 consecutive PICCs during the intervention period) could
exceed $234,717 with the inclusion of length of stay. The average
catheter duration was 18.16 days for cohort 1 and 13.15 days for
cohort 2.
DISCUSSION
In this historical cohort study, there was a signiﬁcant decrease
in adult inpatient premature PICC removals, PICC complications, and
costs following the institution of a multidimensional intervention
utilizing a MECT compared with baseline with no PICC assess-
ment and removal communication and evaluation requirement. This
decrease in premature PICC removals, complications, and costs has
been sustained to date. The decrease in premature PICC removals
1. Leadership Support: 
PICC Removal Protocol
5. Complications & 
adherence audited
4. Managed by a 
Specialty /PICC Team
Leveraging MECT
3. Early Communication: 
MECT - Online PICC 
Assessment/Removal 
Evaluation Referral
2. Collaborative & 
Multidisciplinary
Services by PICC Teams include:
Technical support, Education, 
Complication Monitoring, 
System-wide Policies/Procedures, 
Adherence to Best Practice 
Guidelines
Fig 2. Leveraging the mandataory electronic communication tool (MECT). PICC, peripherally inserted central catheter.
MECT Continuum
PICC 
Request
PICC Insertion Order 
Completed by Ordering Team
PICC Insertion Specialty 
Evaluation
PICC Inserted
Electronic Order Transmittal
Referral Prints out in PICC Office 
& On Unit -> Signed Order in 
Patient Chart Referral Prints out in PICC Office & On Unit -> Signed Order in 
Patient Chart
PICC Removal
PICC Complication 
or Removal Request
Completion of PICC 
Assessment/Removal Referral 
by all teams
Specialty PICC 
Evaluation/Management
Electronic Order Transmittal
Notification of Intervention*
Expedites care/Computer Access*
Multidisciplinary Leadership Support*
Data Collection/Compliance*
Collaboration*
Collaboration &
Paging using CVC list*
Fig 3. Mandatory electronic communication tool continuum. CVC, central venous catheter; PICC, peripherally inserted central catheter.
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Aim 1: 50% decrease in Premature PICC Removal rates
Outcome 1: 85% decrease in premature PICC removal rates, ZERO 
provider led removals
0
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5
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Aim 2: 25% decrease in PICC Complication rates
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68
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Complication 
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45.5%
34%
Outcome 2: 25.3% decrease in PICC complication rates, ZERO 
CLABSI n = 200 per group
P <0.001
Aim 3: 25% decrease in Radiology Costs 
resulting from decreased Premature PICC Removals
Outcome 3: 35.4% decrease in radiology costs
n = 200 per group
PICC Radiology Costs
Total PICCs
Chest x-ray only 
IR Referral
Total imaging costs
Premature removal
additional costs
Total radiology costs
Baseline Group
200
168 (84%)
12 (6%)
$17,924.64
$9,717
$27,641.74
Intervention Group
200
178 (89%)
12 (6%)
$17,863.32
$0
$17,863
p value
1.0
Fig 4. Study outcomes. CLABSI, central line-associated bloodstream infection; IR, interventional radiology; PICC, peripherally inserted central cathter.
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and PICC complications are presumably related to the ability of an
interdisciplinary team to communicate early and collaboratively with
a specialty team to assess and manage PICC complications leading
to PICC removal, following clinical practice guidelines. High com-
pliance was achieved through strong leadership support at the
executive level.
This study adds to the developing body of knowledge associat-
ing early communication and specialty evaluation with reductions
in premature PICC removals, PICC complications, and CLABSI. Our
study is the ﬁrst study focused primarily on a mandatory interven-
tion to decrease premature PICC removals and unique in using
innovative technology, such as an MECT and paging system, for re-
ducing CVC-related complications and costs. Historically, the focus
has always been on reducing CLABSI rates through removing un-
necessary catheters as soon as possible, with less focus on methods
in determining catheter necessity, such as the use of a specialty team
in that decision-making process.
This study was part of an institutional drive to reduce CLABSI
rates across the health system due to an increase in CLABSIs during
2011. An executive leadership-sanctioned multidisciplinary CLABSI
task force was formed and 3 groups developed focusing on CVC in-
sertion, maintenance, and removal. A health system consensus
guideline for the insertion, management, and removal of CVCs was
also developed. These synergistic efforts contributed to the enthu-
siastic buy-in of key interdisciplinary stakeholders, including
members of the pulmonology/critical care and infection control and
epidemiology staff. There was an increased focus on appropriate use
of PICCs, starting from determining the appropriateness and
timing of PICC insertions through the careful and cautious man-
agement of PICC complications and removals. Confounders for
decreased CLABSI rates could have included chlorhexidine bathing
for all patients with CVCs, which started in November 2012, and a
change to standardized central line kits in January 2013. It is im-
portant to note that infection rates had been 0 since the start of study
during late September 2012, before these changes.
A statistically signiﬁcant change in the PICC devise from the Xcela
(Navilyst Medical Inc, Glen Falls, NY) to the PowerPICC FT catheter
(Bard Access Systems Inc, Salt Lake City, UT) (P < .001) was appar-
ent due to a change in the health system PICC purchasing contract
during summer 2012. The catheter was changed from Xcela to
PowerPICC FT due to certain custom kit requirements by the PICC
team; however, the catheters were comparable and had similar char-
acteristics. Both were nonvalved, power-injectable for contrast
studies, and consisted of a polyurethane material. Before use of
Navilyst catheters in 2010, the majority of catheters placed were
nonvalved, nonpower injectable Arrow (Teleﬂex Medical Inc, Re-
search Triangle Park, NC) and nonvalved, power injectable Bard
(power-injectable) catheters. Other catheters had also been trialed,
including power injectable Arrow and AngioDynamics Morpheus
(AngioDynamics Inc, Queensbury, NY) catheters before the change
to Bard PowerPICC FT PICCs. No anecdotal differences in PICC com-
plications and removal related to manufacturer was noted at any
time; however, in 2010, the PICC team elected to use all power-
injectable catheters for increased utility, consistent with the practice
of many other university-aﬃliated health care systems.
A statistical difference in PICC indication (P = .03) and
comorbidities, such as coinfection (P = .02), miscellaneous patient
c-morbidities (P < .0001), and CKD (P < .01) was noted between the
2 cohorts. These differences was presumably related to greater scru-
tiny by the interdisciplinary team for appropriate insertion of PICCs
for intermediate- to long-term access, such as with long-term che-
motherapy and total parenteral nutrition. There was also increased
collaboration with nephrology for vessel preservation in CKD pa-
tients possibly needing future upper extremity dialysis access.
Coinfection refers to any possible source of secondary infection, such
as a urinary tract infection, pneumonia, decubitus ulcer, and abscess.
Due to the higher vigilance by members of the infection preven-
tion team, if there was active fever, increasing leukocytosis,
or suspicion of a bloodstream infection PICC placement was de-
ferred and a peripheral intravenous line placed (including
Cost Implications: 
5 month intervention
*Pronovost, 2006
*
Fig 5. Cost data. CLABSI, central line-associated bloodstream infection; PICC, peripherally inserted central catheter.
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ultrasound-guided peripheral intravenous lines for those with dif-
ﬁcult access). Miscellaneous patient comorbidities referred to any
miscellaneous comorbidities affecting PICC placement and man-
agement not listed in the other comorbidity categories, such as if
the patient had upper arm contractures making PICC placement dif-
ﬁcult, had dementia or impaired cognitive function leading to
premature PICC removal, was homeless or uninsured leading to pre-
mature PICC removal due to inability to continue long-term
antibiotics, had a history of stroke with limited mobility in an ex-
tremity increasing DVT risk, and atrial ﬁbrillation increasing risk for
anticoagulant use and a change in DVT rates. Specialty evaluation
from insertion through removal decreased unnecessary or inap-
propriate insertions leading to premature insertion and removal.
The historical placement of PICCs for intravenously administered
outpatient therapy also decreased. Outpatient agencies are now ex-
pected to place peripheral lines for the majority of short-term
outpatient intravenous access use instead of relying primarily on
PICCs as in the past.
A statistically signiﬁcant difference was also noted in out-
comes between the 2 cohorts for the type of vein used for PICC
placement (P = .001), malposition (P < .001), and reposition (P = .001).
These changes were possibly related to decreases in premature PICC
removal rates (P < .0001), as well as a change in providers (staﬃng
changes for rotating IR nurse practitioners usually occur every
3 months) with differences in vein preference used for PICC
placement (brachial veins are associated with higher risk of com-
plications). Although no signiﬁcant changes were noted between
cohorts for a history of central venous access devices (P = .53), current
central venous access device (P = .12), and reinsertion rates (P = 1.0),
historically these factors also contribute to changes in malposi-
tion and reposition rates.
LIMITATIONS
The limitation of this quality improvement study is that is not
of a randomized, double-blind controlled design and thus cannot
fully exclude confounding variables. The interdisciplinary teamwas
advised to submit a MECT for all PICC assessment and removal re-
quests; however, some chose to use the paging system for early
communication and specialty evaluation rather than the MECT, and
had to be reminded to also complete the MECT for interdisciplin-
ary auditing purposes by infection control and the PICC team. Any
bias on the interpretation of premature PICC removal and CLABSI
was minimized due to an interdisciplinary, collaborative review by
study investigators, infection control and epidemiology depart-
mentmembers, the PICC team, and the study unit. CLABSI rates were
publicly reported to the NHSN and California Department of Health
during the study timeframe.
CONCLUSIONS
At many institutions, the decision to remove PICCs is often clin-
ical. Strict adherence to clinical practice guidelines for PICC removal
may be challenging because the management of these catheters
across its lifespan involves multiple medical and nursing teams with
limited communication with one another. Strong leadership is also
critical for teams focused on programs for the prevention of CLABSI.
Our historical cohort study demonstrates that the facilitation of
early interdisciplinary communication and specialty evaluation,
through innovative methods such as MECT and paging, can in-
crease clinical quality and result in zero provider-led premature PICC
removals and zero CLABSI. As other intervention studies have also
demonstrated in the past, removing PICCs judiciously and not re-
actively, can decrease complications, reduce associated health care
costs, and improve clinical quality. (Figs 1-5)
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